Nonmelanomatous Skin Cancer Global Clinical Trials Review, H1, 2012

Pages: 75 Published: June 01, 2012 Report Code: GDHC1350CTIDB

  • Overview
  • Contents
  • Tables
  • Figures
  • Listen
    iSpeech.org

GlobalData's clinical trial report, “Nonmelanomatous Skin Cancer Global Clinical Trials Review, H1, 2012" provides data on the Nonmelanomatous Skin Cancer/Impaired Glucose Toleranceclinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nonmelanomatous Skin Cancer/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nonmelanomatous Skin Cancer/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Nonmelanomatous Skin Cancer 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Nations 13

Clinical Trials in G7 Nations by Trial Status 14

Clinical Trials by Phase 15

In Progress Trials by Phase 16

Clinical Trials by Trial Status 17

Unaccomplished Trials of Nonmelanomatous Skin Cancer 18

Subjects Recruited Over a Period of Time 20

Prominent Sponsors 21

Top Companies Participating in Nonmelanomatous Skin Cancer Therapeutics Clinical Trials 23

Prominent Drug Comparison 24

Clinical Trial Profiles 25

Clinical Trial Overview of Top Companies 25

Healthpoint Biotherapeutics 25

Clinical Trial Overview of Healthpoint Biotherapeutics 25

DUSA Pharmaceuticals, Inc 26

Clinical Trial Overview of DUSA Pharmaceuticals, Inc 26

Pfizer Inc. 27

Clinical Trial Overview of Pfizer Inc. 27

Clinical Trial Overview of Top Universities / Institutes / Hospitals 28

Roswell Park Cancer Institute 28

Clinical Trial Overview of Roswell Park Cancer Institute 28

The University of Arizona 29

Clinical Trial Overview of The University of Arizona 29

Case Comprehensive Cancer Center 30

Clinical Trial Overview of Case Comprehensive Cancer Center 30

University of Alabama at Birmingham 31

Clinical Trial Overview of University of Alabama at Birmingham 31

University of Wisconsin Madison 32

Clinical Trial Overview of University of Wisconsin Madison 32

Children's Hospital & Research Center Oakland 33

Clinical Trial Overview of Children's Hospital & Research Center Oakland 33

Royal Adelaide Hospital 34

Clinical Trial Overview of Royal Adelaide Hospital 34

The Queen's Medical Center 35

Clinical Trial Overview of The Queen's Medical Center 35

Oregon Health and Science University 36

Clinical Trial Overview of Oregon Health and Science University 36

University Hospital Basel 37

Clinical Trial Overview of University Hospital Basel 37

Abramson Cancer Center 38

Clinical Trial Overview of Abramson Cancer Center 38

Mayo Clinic 39

Clinical Trial Overview of Mayo Clinic 39

Eastern Virginia Medical School 40

Clinical Trial Overview of Eastern Virginia Medical School 40

Yale University 41

Clinical Trial Overview of Yale University 41

Hoag Memorial Hospital Presbyterian 42

Clinical Trial Overview of Hoag Memorial Hospital Presbyterian 42

Baylor College of Medicine 43

Clinical Trial Overview of Baylor College of Medicine 43

The Medical University of Graz 44

Clinical Trial Overview of The Medical University of Graz 44

Northwestern University 45

Clinical Trial Overview of Northwestern University 45

University of Massachusetts 46

Clinical Trial Overview of University of Massachusetts 46

University of California, Irvine 47

Clinical Trial Overview of University of California, Irvine 47

Five Key Clinical Profiles 48

Appendix 72

Abbreviations 72

Definitions 72

Research Methodology 73

Secondary Research 73

About GlobalData 74

Contact Us 74

Disclaimer 74

Source 75

List of Tables

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 12

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 13

Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 14

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 15

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 16

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 17

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 18

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 19

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 20

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 22

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 23

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 24

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics, 2012* 25

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by DUSA Pharmaceuticals, Inc, 2012* 26

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 27

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 28

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Arizona, 2012* 29

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 30

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012* 31

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 32

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital & Research Center Oakland, 2012* 33

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2012* 34

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Queen's Medical Center, 2012* 35

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2012* 36

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2012* 37

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012* 38

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 39

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2012* 40

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012* 41

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoag Memorial Hospital Presbyterian, 2012* 42

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2012* 43

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012* 44

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 45

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012* 46

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012* 47

List of Figures

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 13

Nonmelanomatous Skin Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 14

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 15

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 16

Nonmelanomatous Skin Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 17

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 20

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 21

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 23

Nonmelanomatous Skin Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 24

GlobalData Methodology 73

$2500

Can be used by individual purchaser only

$7500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.